⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Fucose SCHEMBL525352 | 1.00 | — | — | |
| L-Fucose SCHEMBL16703726 | 1.00 | — | — | |
| L-Fucose SCHEMBL14830475 | 1.00 | — | — | |
| L-Fucose SCHEMBL5072536 | 1.00 | — | — | |
| L-Fucose SCHEMBL25051 | 1.00 | — | — | |
| L-Fucose SCHEMBL466429 | 1.00 | — | — | |
| L-Fucose SCHEMBL2597764 | 1.00 | — | — | |
| L-Fucose SCHEMBL1746724 | 1.00 | — | — | |
| L-Fucose SCHEMBL11347428 | 1.00 | — | — | |
| L-Fucose SCHEMBL1458729 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116472346-A | Production of sialylated oligosaccharide mixtures by cells | 因比奥斯公司 | 2023-07-21 | — | — | CN | claimed |
| CN-116323958-A | Production of oligosaccharide mixtures by cells | 因比奥斯公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116249781-A | Production of biological products containing GlcNAc in cells | 因比奥斯公司 | 2023-06-09 | — | — | CN | claimed |
| CN-116234919-A | Production of mixtures of neutral fucosylated oligosaccharides by cells | 因比奥斯公司 | 2023-06-06 | — | — | CN | claimed |
| CN-116096911-A | Production of oligosaccharide mixtures by cells | 因比奥斯公司 | 2023-05-09 | — | — | CN | claimed |
| CN-116096912-A | Production of a mixture of neutral nonfucosylated oligosaccharides by cells | 因比奥斯公司 | 2023-05-09 | — | — | CN | claimed |
| EP-0400064-A1 | SOLID CATALYSTS FOR CONTINUOUS INTERCONVERSION OF EPIMERIC ALDOSES AND ALDOSE ANALOGS. | ALLIED SIGNAL INC (US) | 1990-12-05 | — | — | EP | claimed |
| WO-1989007602-A1 | SOLID CATALYSTS FOR CONTINUOUS INTERCONVERSION OF EPIMERIC ALDOSES AND ALDOSE ANALOGS | ALLIED-SIGNAL INC. (US) | 1989-08-24 | — | — | WO | claimed |
| US-20230277432-A1 | COMPOSITION FOR IMPROVING THE APPEARANCE OF AGEING SKIN | MERZ PHARMA GMBH & CO. KGAA (DE) | 2023-09-07 | — | — | US | disclosed |
| US-11712435-B2 | Mebendazole prodrugs with enhanced solubility and oral bioavailability | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-08-01 | — | — | US | disclosed |
| CN-116472346-A | Production of sialylated oligosaccharide mixtures by cells | 因比奥斯公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-116323930-A | Cell production of sialylated di-and/or oligosaccharides | 因比奥斯公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116323958-A | Production of oligosaccharide mixtures by cells | 因比奥斯公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116323927-A | Cell production of di-and/or oligosaccharides | 因比奥斯公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-2241556-A1 | METHOD FOR THE PREPARATION OF CAPECITABINE AND INTERMEDIATES USED IN SAID METHOD | Coll Farma S.L. (ES) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009071726-A1 | METHOD FOR THE PREPARATION OF CAPECITABINE AND INTERMEDIATES USED IN SAID METHOD | COLL FARMA S.L. (ES) | 2009-06-11 | — | — | WO | disclosed |
| EP-0400064-B1 | SOLID CATALYSTS FOR CONTINUOUS INTERCONVERSION OF EPIMERIC ALDOSES AND ALDOSE ANALOGS | UOP (US) | 1993-04-21 | — | — | EP | disclosed |
| EP-0400064-A1 | SOLID CATALYSTS FOR CONTINUOUS INTERCONVERSION OF EPIMERIC ALDOSES AND ALDOSE ANALOGS. | ALLIED SIGNAL INC (US) | 1990-12-05 | — | — | EP | disclosed |
| WO-1989007602-A1 | SOLID CATALYSTS FOR CONTINUOUS INTERCONVERSION OF EPIMERIC ALDOSES AND ALDOSE ANALOGS | ALLIED-SIGNAL INC. (US) | 1989-08-24 | — | — | WO | disclosed |
| US-4815445-A | ANION EXCHANGE RESIN | ALLIED-SIGNAL INC. (US) | 1989-03-28 | — | — | US | disclosed |